SMR Is Up 19% in a Week. The Paragon Deal Is Not the Reason to Watch It.
NuScale just hit a new near-term high after the HIPS safety contract. The TVA program, the $1B liquidity runway, and…
NuScale just hit a new near-term high after the HIPS safety contract. The TVA program, the $1B liquidity runway, and…
A steep one-day drop, an $84.75B equity raise, and a stock still well off its high. Here's what traders need…
The Blackwell ramp, Vera CPU debut, and a multiyear SK hynix partnership are the real agenda items. The options market…
TJX, ROST, and the off-price retailers quietly eating the entire retail sector alive.
Jensen Huang called it the next trillion-dollar company. Wall Street's average price target still sits below where shares trade. That…
Software just outran semiconductors in May. Most investors missed it.
Oral pills, Medicare coverage, and a triple-hormone drug showing bariatric-level weight loss. LLY is not done.
MSFT stock has been the megacap laggard of 2026. Azure at 40% growth and a $37B AI run rate say…
ORCL fell 10% on record results. The $638 billion backlog says the selloff may be the story investors actually want.
The Apple–Intel chip deal is real enough to move markets — but the questions it raises are bigger than the…